PLC Medical Systems to Demonstrate RenalGuard(R) a... ( FRANKLIN Mass. Aug. 31 /-...)

PLC Medical Systems to Demonstrate RenalGuard(R) at ESC 2009

Date:8/31/2009

FRANKLIN, Mass., Aug. 31 /PRNewswire-FirstCall/ -- PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today announced that it will demonstrate its RenalGuard System(TM) at ESC Congress 2009, the annual meeting of the European Society of Cardiology, August 29 - September 2, 2009 in Barcelona, Spain. More than 30,000 clinicians and professionals are expected to attend this event.

In addition, Dr. Giancarlo Marenzi, Chief, Intensive Cardiac Care Unit, Centro Cardiologico Monzino-University of Milan (CCM) will present preliminary results of the MYTHOS investigator-sponsored clinical trial of RenalGuard.

In an update to the abstract published in late August, Dr. Marenzi is presenting initial results that indicate that patients with high risk for renal failure treated with RenalGuard((R) )while undergoing imaging procedures acquired contrast-induced nephropathy (CIN) at less than half the rate of those who were treated beforehand with overnight hydration. Acquiring CIN has been found to lead to a range of serious and potentially deadly outcomes in patients who already have compromised kidney function.

Mark R. Tauscher, president and chief executive officer of PLC Systems, said, "We are extremely pleased with these very positive preliminary results of the MYTHOS clinical trial, since they greatly exceed the primary endpoint, which is defined as equivalency. These initial results confirm the initial direction seen in the earlier abstract, and provide strong evidence that RenalGuard is highly effective in reducing the incidence of CIN in millions of high-risk patients around the world every year. With these initial positive results in hand, we are firmly focused on accelerating the pace of signing up distributors in Europe and expanding our launch of RenalGuard to additional international markets."

SOURCE PLC Systems Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Former Veterans Affairs Secretary Joins Integrated Medical Systems Advisory Board
2. Provider of Diabetes Medical Supplies Receives 2009 Best of Boca Raton Award
3. Orion Health and Cisco Announce New Medical Data Exchange Solution to Integrate, Share and Report Public Health Data
4. Varian Medical Systems Adds RapidArc(R) and Image Guidance to New Low Energy Treatment Platform for Radiation Therapy in International Cancer Clinics
5. Boston Scientific Names Leading Electrophysiologist to Its Medical Team
6. Solve Skin Conditions and Receive Hair Loss Treatment from Home with New Line of Medical Devices Called Dermaray
7. Foreign Physician Growth in the U.S. and the Impact on Medical Credentialing
8. ReBuilder Medical Technologies, Inc. Announces Negotiations with National Medicare Provider
9. China Sky One Medical, Inc. to Hold Annual Meeting of Shareholders on September 24, 2009
10. Radiologists, medical physicists work to make imaging procedures safer
11. The Feinstein Institute for Medical Research Discovers the Role of Progesterone and Pre-Term Labor

Post Your Comments:

(Date:12/15/2009)... -- Reportlinker.com announces that a new ... its catalogue: ,, The ... Market Forecasts to 2015, Competitive Benchmarking, ... ,, http://www.reportlinker.com/p0168100/The-Future-of-Autoimmune-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, ... has released its latest research "The ...

(Date:12/15/2009)... -- Hosted by the Technology-based Learning SIG of ... 2009,s best eLearning designs. This year nominees, ... categories. The Venza Group entry, a highly ... hotelier, was selected as the winner of the ... by the panel of distinguished judges. While ...

(Date:12/15/2009)... CHENNAI, India, Dec. 15 Hospira, ... world leader in generic injectable pharmaceuticals, and ... NSE: ORCHIDCHEM), a leading Indian pharmaceuticals company ... manufacturers globally, today announced an agreement for ... form pharmaceuticals business for approximately $400 million. ...

(Date:12/15/2009)... CHICAGO, Dec. 15 The following is being ... ,, Remarks by: Vera Rulon, MS, RHIT, CCS, ... morning, everyone and thank you joining us... ,, On ... great pleasure to introduce our next chief executive officer, ... embarked on a nationwide search for someone who we ...

(Date:12/15/2009)... are often treated with hormones, but when the tumours ... vessels, reveals a thesis from the Sahlgrenska Academy, at ... way for new treatments for hormone-resistant prostate cancer. , ... prostate cancer has spread, most patients are given hormone ... hormone and the tumour shrinks. , "The problem is ...

[0] Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] The Venza Group Received Top Honors at the American Society of Training & Development (ASTD) eLearning Excellence Awards Ceremony Held on December 10, 2009 [0] Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business [0] Dowling Press Availability Tuesday, December 15, 2009 / 10:00 a.m. CST [0] More blood vessels in hormone-resistant prostate tumors

... THRM ), a leader in non-invasive tissue tightening in ... quarter ended,September 30, 2008. Reliant Technologies, Inc. also reported ... for the third quarter of 2008 was $13.0 million, ... quarter of 2007. Domestic,revenue decreased 10% and international revenue ...

... Nov. 10 Hospira, Inc.,(NYSE: HSP ), ... today that Ken Meyers has been named senior ... he will lead the global human resources function ... organizational excellence.,Meyers succeeds Henry Weishaar, who is retiring ...

... Ignagni, President,and CEO of America,s Health Insurance Plans ... announced by CMS on agent and broker,compensation for ... taking this important step to provide guidelines,for agent ... receive the,information they need during open enrollment, that ...

... GmbH has,successfully completed Phase I and Phase II ... formulation delivered via a,customized Investigational eFlow Nebulizer System ... PLUS jet nebulizer. While key,deposition and safety thresholds ... the average inhalation time to 4 - 4 ...

... Comes to Encouraging Smokers to ... Quit, New Survey Finds, PITTSBURGH, Pa., ... of its kind stop-smoking gum with a whitening,benefit. Nicorette(R) White Ice Mint ... with tough cravings and withdrawal,symptoms, but also helps whiten teeth.(1) A new ...

... re-opens in centrally located Family First Health Center; Members now have ... access by public ... Pharmacy celebrated its grand re-opening at 116 South George,Street in York, ... thousands of local York residents who are part of the,Healthy York ...

Other Medicine News:Health News:Thermage Reports Third Quarter Financial Results and Provides Information Regarding Reliant's Results 2 Health News:Thermage Reports Third Quarter Financial Results and Provides Information Regarding Reliant's Results 3 Health News:Thermage Reports Third Quarter Financial Results and Provides Information Regarding Reliant's Results 4 Health News:Thermage Reports Third Quarter Financial Results and Provides Information Regarding Reliant's Results 5 Health News:Thermage Reports Third Quarter Financial Results and Provides Information Regarding Reliant's Results 6 Health News:Thermage Reports Third Quarter Financial Results and Provides Information Regarding Reliant's Results 7 Health News:Thermage Reports Third Quarter Financial Results and Provides Information Regarding Reliant's Results 8 Health News:Thermage Reports Third Quarter Financial Results and Provides Information Regarding Reliant's Results 9 Health News:Hospira Names Ken Meyers to Lead Human Resources 2 Health News:PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF 2 Health News:PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF 3 Health News:PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF 4 Health News:New Stop Smoking Aid Offers Unique Teeth Whitening Benefit 2 Health News:New Stop Smoking Aid Offers Unique Teeth Whitening Benefit 3 Health News:New Stop Smoking Aid Offers Unique Teeth Whitening Benefit 4 Health News:Capital BlueCross Sponsors Healthy Community Pharmacy's Move to New Community-Focused Location in York 2 Health News:Capital BlueCross Sponsors Healthy Community Pharmacy's Move to New Community-Focused Location in York 3

Thermage Reports Third Quarter Financial Results and Provides Information Regarding Reliant's Results Hospira Names Ken Meyers to Lead Human Resources AHIP Statement on New CMS Guidelines for Agent and Broker Commissions in Medicare Advantage PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF New Stop Smoking Aid Offers Unique Teeth Whitening Benefit Capital BlueCross Sponsors Healthy Community Pharmacy's Move to New Community-Focused Location in York

(Date:12/15/2009)... Safe Life Corp ., an innovative antimicrobial ... the spread of infection and disease, announced today ... breathable, A400 Series respirator to help healthcare providers ... N95 respirators during the H1N1 pandemic. The company ... rapid rise in demand and now is capable ...

(Date:12/15/2009)... 15 Vivakor, Inc. (OTC Bulletin ... have reported strong performance in 2009. Vivakor ... development with divisional spokes developing multiple products ... Pipeline strategy is anchored to the concept ... inception, Vivakor,s R&D efforts target commercialization and ...

(Date:12/15/2009)... N.J., Dec. 15 HealthLeaders-InterStudy and Fingertip ... directors expect to cover Pfizer,s tanezumab if it ... Tanezumab, which is expected to be the first ... intravenously under medical supervision, will likely be covered ... benefit according to surveyed pharmacy directors. According to ...

Breaking Medicine Technology:Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage 2 Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage 3 Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage 4 Vivakor Divisions Continue to Demonstrate Independent Growth 2 Majority of Surveyed Pharmacy Directors Expect To Cover Pfizer's Tanezumab If It Is Approved for the Treatment of Chronic Pain 2 Majority of Surveyed Pharmacy Directors Expect To Cover Pfizer's Tanezumab If It Is Approved for the Treatment of Chronic Pain 3 Oklahoma scientists discover promising new path for treating traumas 60039 1 Oklahoma scientists discover promising new path for treating traumas 60039 2 Study shows how carbon nanotubes can affect lining of the lungs 10514 1 Study shows how carbon nanotubes can affect lining of the lungs 10514 2 Master regulator found for regenerating nerve fibers in live animals 10511 1 Master regulator found for regenerating nerve fibers in live animals 10511 2

[0] Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage [0] Vivakor Divisions Continue to Demonstrate Independent Growth [0] Majority of Surveyed Pharmacy Directors Expect To Cover Pfizer's Tanezumab If It Is Approved for the Treatment of Chronic Pain

... /PRNewswire-USNewswire/ -- Rear,Admiral Timothy Ziemer (U.S. Navy, retired), ... Dr. Bernard,Nahlen to serve as Deputy Coordinator of ... Commissioned Officer in the U.S.,Public Heath Service and ... Evaluation, at the Global Fund to Fight,AIDS, Tuberculosis ...

... cultivated from patients' own blood can,potentially improve ... lower,extremities are affected by peripheral vascular disease, ... July 02, 2007 /PRNewswire/ -- Beike,Biotechnology Co., ... a team led by Dr. Yang Xiaofeng ...

Other Medicine Technology:Studies of Drug Resistance May Lead to Individual Therapy for Rare,Cancers 2 Beike Biotechnology Study Suggests Adult Stem Cells Show Promise,for Peripheral Vascular Disease 2 Beike Biotechnology Study Suggests Adult Stem Cells Show Promise,for Peripheral Vascular Disease 3

Studies of Drug Resistance May Lead to Individual Therapy for Rare,Cancers Beike Biotechnology Study Suggests Adult Stem Cells Show Promise,for Peripheral Vascular Disease

The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...

... is a wearable CPAP (Continuous Positive Airway ... apnea. The lightweight BreatheX CPAP device (patent ... its built-in, rechargeable battery, and is mobile, ... longer need to be "plugged in to ...

Paraffin Block Storage System...

Shandon Paraffin Block Cabinet...

Medicine Products:

Tag-It Cystic Fibrosis PCR Mix BreatheX™ CPAP device Paraffin Block Storage System Shandon Paraffin Block Cabinet

PLC Medical Systems to Demonstrate RenalGuard(R) a...( FRANKLIN Mass. Aug. 31 /-...),Health